+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Immunoprotein Diagnostic Testing Market - Global Forecast 2026-2032- Product Image
Immunoprotein Diagnostic Testing Market - Global Forecast 2026-2032- Product Image
New

Immunoprotein Diagnostic Testing Market - Global Forecast 2026-2032

  • PDF Icon

    Report

  • 193 Pages
  • January 2026
  • Region: Global
  • 360iResearch™
  • ID: 5888817
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Immunoprotein diagnostic testing is rapidly influencing laboratory medicine and healthcare delivery, offering capabilities that power clinical decisions, monitoring, and research innovation. Senior leaders in diagnostics and healthcare must recognize how this dynamic market segment can accelerate lab effectiveness and support sustained organizational growth.

Market Snapshot: Immunoprotein Diagnostic Testing Market Overview

The Immunoprotein Diagnostic Testing Market is demonstrating robust expansion, increasing from USD 10.07 billion in 2025 to USD 10.79 billion in 2026, with further momentum projected to reach USD 16.32 billion by 2032 at a CAGR of 7.13%. This positive trajectory reflects how advanced immunoprotein tests are now essential in both standard and specialized healthcare settings, reinforcing the strategic importance of innovation and integration within diagnostics for future growth.

Scope & Segmentation Across the Immunoprotein Diagnostics Landscape

  • Assay Types: Includes antibody, antigen, and autoantibody panels, enabling applications from infectious diseases to oncology and autoimmune condition management.
  • Immunoglobulin Classes: Focuses on IgA, IgE, IgG, and IgM detection, supporting acute infection diagnosis, immunodeficiency analysis, and allergy care initiatives.
  • Platform Technologies: Covers chemiluminescent immunoassays, ELISA, fluorescence polarization, lateral flow, and Western blot, each suited for specific throughput, automation, and point-of-care uses.
  • End Users: Ranges from clinics and hospitals to research institutes and diagnostic labs, each with distinct regulatory demands and operational workflows.
  • Clinical Applications: Encompasses autoimmune disease stratification, cardiovascular monitoring, infectious disease evaluation—including applications such as COVID-19, hepatitis, and HIV—and oncology and personalized therapy support.
  • Sample Types: Utilizes plasma, serum, urine, and whole blood, shaping preanalytical processes and validation approaches.
  • Regions: Covers Americas, Europe, Middle East & Africa, and Asia-Pacific, highlighting regional trends, innovation drivers, and varying regulatory factors.
  • Workflow Integration: Prioritizes procurement efficiency, data interoperability, and automation in both centralized and decentralized environments.

Key Takeaways for Decision-Makers

  • Immunoprotein diagnostic testing is now central to clinical routines, providing results essential for diagnosis, therapy guidance, and effective monitoring.
  • Advancements in assay sensitivity and multiplex capability are expanding the clinical questions addressed, enhancing both the speed and reliability of testing workflows.
  • Automation and digital integration with lab information systems are increasing traceability and compliance, supporting labs in scaling operations and meeting quality demands.
  • Heightened regulatory attention on validation and post-market monitoring is affecting procurement and product approval strategies for both laboratories and manufacturers.
  • Growing reliance on multiplexed quantitative formats reflects the critical nature of therapeutic monitoring and underlines the strategic growth of companion diagnostics.
  • Collaboration between reagent suppliers and instrument vendors is driving more rapid innovation in assay offerings, equipping labs with new clinical capabilities.

Tariff Impact on Supply Chains and Procurement Strategies

The 2025 United States tariff updates have had lasting effects on diagnostic supply chains. In response, manufacturers diversified their supplier networks and shifted to nearshoring to minimize risk from price and shipping volatility. Labs also refined inventory systems, optimized reagent usage, and pursued bundled contracts to control costs and ensure consistent supply. These actions have collectively increased resilience and heightened attention on assay efficiency and the agility of supply models.

Methodology & Data Sources

This analysis integrates direct input from laboratory directors, procurement officers, and research scientists with extensive secondary research from scientific publications, regulatory records, and technical standards. Findings have been validated and are supported by practical case studies, ensuring relevance for executive decision-making and reproducibility of insights.

Why This Report Matters to Senior Leaders

  • Enables informed evaluation of technology investment, procurement, and supplier strategies, guiding responses to fast-changing diagnostic markets.
  • Clarifies strategic implications of regulatory, manufacturing, and supply chain shifts, supporting sustainable business decisions and improved competitive positioning.
  • Prepares executives and innovators with applied insights to align laboratory operations, resource allocation, and partnerships with evolving clinical and commercial needs.

Conclusion: Strategic Relevance for Immunoprotein Diagnostics

Immunoprotein diagnostic testing continues to evolve, backed by innovation, regulatory advances, and adaptable business models. Organizations that align their products and workflows to emerging standards will be well positioned for leadership and resilience in this critical sector.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Porter’s Five Forces Analysis
4.4. PESTLE Analysis
4.5. Market Outlook
4.5.1. Near-Term Market Outlook (0-2 Years)
4.5.2. Medium-Term Market Outlook (3-5 Years)
4.5.3. Long-Term Market Outlook (5-10 Years)
4.6. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025
8. Immunoprotein Diagnostic Testing Market, by Assay Type
8.1. Antibody Test
8.1.1. Iga
8.1.2. Ige
8.1.3. Igg
8.1.4. Igm
8.1.5. Total Antibody
8.2. Antigen Test
8.3. Autoantibody Test
9. Immunoprotein Diagnostic Testing Market, by Technology
9.1. Clia
9.2. Elisa
9.3. Fluorescence Polarization Immunoassay
9.4. Lateral Flow Immunoassay
9.5. Western Blot
10. Immunoprotein Diagnostic Testing Market, by End User
10.1. Clinic
10.2. Diagnostic Laboratory
10.3. Hospital
10.4. Research Institute
11. Immunoprotein Diagnostic Testing Market, by Application
11.1. Autoimmune Disorders
11.1.1. Multiple Sclerosis
11.1.2. Rheumatoid Arthritis
11.1.3. Sjogren Syndrome
11.1.4. Type 1 Diabetes
11.2. Cardiovascular Diseases
11.3. Infectious Diseases
11.3.1. COVID-19
11.3.2. Hepatitis
11.3.3. Hiv
11.3.4. Influenza
11.4. Oncology
12. Immunoprotein Diagnostic Testing Market, by Sample Type
12.1. Plasma
12.2. Serum
12.3. Urine
12.4. Whole Blood
13. Immunoprotein Diagnostic Testing Market, by Region
13.1. Americas
13.1.1. North America
13.1.2. Latin America
13.2. Europe, Middle East & Africa
13.2.1. Europe
13.2.2. Middle East
13.2.3. Africa
13.3. Asia-Pacific
14. Immunoprotein Diagnostic Testing Market, by Group
14.1. ASEAN
14.2. GCC
14.3. European Union
14.4. BRICS
14.5. G7
14.6. NATO
15. Immunoprotein Diagnostic Testing Market, by Country
15.1. United States
15.2. Canada
15.3. Mexico
15.4. Brazil
15.5. United Kingdom
15.6. Germany
15.7. France
15.8. Russia
15.9. Italy
15.10. Spain
15.11. China
15.12. India
15.13. Japan
15.14. Australia
15.15. South Korea
16. United States Immunoprotein Diagnostic Testing Market
17. China Immunoprotein Diagnostic Testing Market
18. Competitive Landscape
18.1. Market Concentration Analysis, 2025
18.1.1. Concentration Ratio (CR)
18.1.2. Herfindahl Hirschman Index (HHI)
18.2. Recent Developments & Impact Analysis, 2025
18.3. Product Portfolio Analysis, 2025
18.4. Benchmarking Analysis, 2025
18.5. Abbott Laboratories
18.6. Bio-Rad Laboratories, Inc.
18.7. bioMérieux SA
18.8. Danaher Corporation
18.9. DiaSorin S.p.A
18.10. F. Hoffmann-La Roche Ltd
18.11. Fujirebio Inc
18.12. Ortho-Clinical Diagnostics, Inc.
18.13. Siemens Healthineers AG
18.14. Thermo Fisher Scientific Inc
List of Figures
FIGURE 1. GLOBAL IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 2. GLOBAL IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 3. GLOBAL IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET, FPNV POSITIONING MATRIX, 2025
FIGURE 4. GLOBAL IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY ASSAY TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 5. GLOBAL IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 6. GLOBAL IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 7. GLOBAL IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY SAMPLE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 9. GLOBAL IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 11. GLOBAL IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. UNITED STATES IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 13. CHINA IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, 2018-2032 (USD MILLION)
List of Tables
TABLE 1. GLOBAL IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 2. GLOBAL IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY ASSAY TYPE, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY ANTIBODY TEST, BY REGION, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY ANTIBODY TEST, BY GROUP, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY ANTIBODY TEST, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY ANTIBODY TEST, 2018-2032 (USD MILLION)
TABLE 7. GLOBAL IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY IGA, BY REGION, 2018-2032 (USD MILLION)
TABLE 8. GLOBAL IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY IGA, BY GROUP, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY IGA, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY IGE, BY REGION, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY IGE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY IGE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY IGG, BY REGION, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY IGG, BY GROUP, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY IGG, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY IGM, BY REGION, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY IGM, BY GROUP, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY IGM, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY TOTAL ANTIBODY, BY REGION, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY TOTAL ANTIBODY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY TOTAL ANTIBODY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY ANTIGEN TEST, BY REGION, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY ANTIGEN TEST, BY GROUP, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY ANTIGEN TEST, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY AUTOANTIBODY TEST, BY REGION, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY AUTOANTIBODY TEST, BY GROUP, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY AUTOANTIBODY TEST, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY CLIA, BY REGION, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY CLIA, BY GROUP, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY CLIA, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY ELISA, BY REGION, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY ELISA, BY GROUP, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY ELISA, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY FLUORESCENCE POLARIZATION IMMUNOASSAY, BY REGION, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY FLUORESCENCE POLARIZATION IMMUNOASSAY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY FLUORESCENCE POLARIZATION IMMUNOASSAY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY LATERAL FLOW IMMUNOASSAY, BY REGION, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY LATERAL FLOW IMMUNOASSAY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY LATERAL FLOW IMMUNOASSAY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY WESTERN BLOT, BY REGION, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY WESTERN BLOT, BY GROUP, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY WESTERN BLOT, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY CLINIC, BY REGION, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY CLINIC, BY GROUP, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY CLINIC, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORY, BY REGION, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 50. GLOBAL IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 51. GLOBAL IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY HOSPITAL, BY REGION, 2018-2032 (USD MILLION)
TABLE 52. GLOBAL IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY HOSPITAL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 53. GLOBAL IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY HOSPITAL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 54. GLOBAL IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY RESEARCH INSTITUTE, BY REGION, 2018-2032 (USD MILLION)
TABLE 55. GLOBAL IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY RESEARCH INSTITUTE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 56. GLOBAL IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY RESEARCH INSTITUTE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 57. GLOBAL IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 58. GLOBAL IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY AUTOIMMUNE DISORDERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 59. GLOBAL IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY AUTOIMMUNE DISORDERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 60. GLOBAL IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY AUTOIMMUNE DISORDERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 61. GLOBAL IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY AUTOIMMUNE DISORDERS, 2018-2032 (USD MILLION)
TABLE 62. GLOBAL IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY MULTIPLE SCLEROSIS, BY REGION, 2018-2032 (USD MILLION)
TABLE 63. GLOBAL IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY MULTIPLE SCLEROSIS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 64. GLOBAL IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY MULTIPLE SCLEROSIS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 65. GLOBAL IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY RHEUMATOID ARTHRITIS, BY REGION, 2018-2032 (USD MILLION)
TABLE 66. GLOBAL IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY RHEUMATOID ARTHRITIS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 67. GLOBAL IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY RHEUMATOID ARTHRITIS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 68. GLOBAL IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY SJOGREN SYNDROME, BY REGION, 2018-2032 (USD MILLION)
TABLE 69. GLOBAL IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY SJOGREN SYNDROME, BY GROUP, 2018-2032 (USD MILLION)
TABLE 70. GLOBAL IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY SJOGREN SYNDROME, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 71. GLOBAL IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY TYPE 1 DIABETES, BY REGION, 2018-2032 (USD MILLION)
TABLE 72. GLOBAL IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY TYPE 1 DIABETES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 73. GLOBAL IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY TYPE 1 DIABETES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 74. GLOBAL IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY REGION, 2018-2032 (USD MILLION)
TABLE 75. GLOBAL IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 76. GLOBAL IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 77. GLOBAL IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2032 (USD MILLION)
TABLE 78. GLOBAL IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY INFECTIOUS DISEASES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 79. GLOBAL IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY INFECTIOUS DISEASES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 80. GLOBAL IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2032 (USD MILLION)
TABLE 81. GLOBAL IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY COVID-19, BY REGION, 2018-2032 (USD MILLION)
TABLE 82. GLOBAL IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY COVID-19, BY GROUP, 2018-2032 (USD MILLION)
TABLE 83. GLOBAL IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY COVID-19, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 84. GLOBAL IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY HEPATITIS, BY REGION, 2018-2032 (USD MILLION)
TABLE 85. GLOBAL IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY HEPATITIS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 86. GLOBAL IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY HEPATITIS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 87. GLOBAL IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY HIV, BY REGION, 2018-2032 (USD MILLION)
TABLE 88. GLOBAL IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY HIV, BY GROUP, 2018-2032 (USD MILLION)
TABLE 89. GLOBAL IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY HIV, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 90. GLOBAL IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY INFLUENZA, BY REGION, 2018-2032 (USD MILLION)
TABLE 91. GLOBAL IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY INFLUENZA, BY GROUP, 2018-2032 (USD MILLION)
TABLE 92. GLOBAL IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY INFLUENZA, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 93. GLOBAL IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2032 (USD MILLION)
TABLE 94. GLOBAL IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY ONCOLOGY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 95. GLOBAL IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY ONCOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 96. GLOBAL IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 97. GLOBAL IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY PLASMA, BY REGION, 2018-2032 (USD MILLION)
TABLE 98. GLOBAL IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY PLASMA, BY GROUP, 2018-2032 (USD MILLION)
TABLE 99. GLOBAL IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY PLASMA, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 100. GLOBAL IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY SERUM, BY REGION, 2018-2032 (USD MILLION)
TABLE 101. GLOBAL IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY SERUM, BY GROUP, 2018-2032 (USD MILLION)
TABLE 102. GLOBAL IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY SERUM, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 103. GLOBAL IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY URINE, BY REGION, 2018-2032 (USD MILLION)
TABLE 104. GLOBAL IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY URINE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 105. GLOBAL IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY URINE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 106. GLOBAL IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY WHOLE BLOOD, BY REGION, 2018-2032 (USD MILLION)
TABLE 107. GLOBAL IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY WHOLE BLOOD, BY GROUP, 2018-2032 (USD MILLION)
TABLE 108. GLOBAL IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY WHOLE BLOOD, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 109. GLOBAL IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 110. AMERICAS IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 111. AMERICAS IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY ASSAY TYPE, 2018-2032 (USD MILLION)
TABLE 112. AMERICAS IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY ANTIBODY TEST, 2018-2032 (USD MILLION)
TABLE 113. AMERICAS IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 114. AMERICAS IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 115. AMERICAS IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 116. AMERICAS IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY AUTOIMMUNE DISORDERS, 2018-2032 (USD MILLION)
TABLE 117. AMERICAS IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2032 (USD MILLION)
TABLE 118. AMERICAS IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 119. NORTH AMERICA IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 120. NORTH AMERICA IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY ASSAY TYPE, 2018-2032 (USD MILLION)
TABLE 121. NORTH AMERICA IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY ANTIBODY TEST, 2018-2032 (USD MILLION)
TABLE 122. NORTH AMERICA IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 123. NORTH AMERICA IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 124. NORTH AMERICA IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 125. NORTH AMERICA IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY AUTOIMMUNE DISORDERS, 2018-2032 (USD MILLION)
TABLE 126. NORTH AMERICA IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2032 (USD MILLION)
TABLE 127. NORTH AMERICA IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 128. LATIN AMERICA IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 129. LATIN AMERICA IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY ASSAY TYPE, 2018-2032 (USD MILLION)
TABLE 130. LATIN AMERICA IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY ANTIBODY TEST, 2018-2032 (USD MILLION)
TABLE 131. LATIN AMERICA IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 132. LATIN AMERICA IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 133. LATIN AMERICA IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 134. LATIN AMERICA IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY AUTOIMMUNE DISORDERS, 2018-2032 (USD MILLION)
TABLE 135. LATIN AMERICA IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2032 (USD MILLION)
TABLE 136. LATIN AMERICA IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 137. EUROPE, MIDDLE EAST & AFRICA IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 138. EUROPE, MIDDLE EAST & AFRICA IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY ASSAY TYPE, 2018-2032 (USD MILLION)
TABLE 139. EUROPE, MIDDLE EAST & AFRICA IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY ANTIBODY TEST, 2018-2032 (USD MILLION)
TABLE 140. EUROPE, MIDDLE EAST & AFRICA IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 141. EUROPE, MIDDLE EAST & AFRICA IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 142. EUROPE, MIDDLE EAST & AFRICA IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 143. EUROPE, MIDDLE EAST & AFRICA IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY AUTOIMMUNE DISORDERS, 2018-2032 (USD MILLION)
TABLE 144. EUROPE, MIDDLE EAST & AFRICA IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2032 (USD MILLION)
TABLE 145. EUROPE, MIDDLE EAST & AFRICA IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 146. EUROPE IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 147. EUROPE IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY ASSAY TYPE, 2018-2032 (USD MILLION)
TABLE 148. EUROPE IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY ANTIBODY TEST, 2018-2032 (USD MILLION)
TABLE 149. EUROPE IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 150. EUROPE IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 151. EUROPE IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 152. EUROPE IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY AUTOIMMUNE DISORDERS, 2018-2032 (USD MILLION)
TABLE 153. EUROPE IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2032 (USD MILLION)
TABLE 154. EUROPE IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 155. MIDDLE EAST IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 156. MIDDLE EAST IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY ASSAY TYPE, 2018-2032 (USD MILLION)
TABLE 157. MIDDLE EAST IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY ANTIBODY TEST, 2018-2032 (USD MILLION)
TABLE 158. MIDDLE EAST IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 159. MIDDLE EAST IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 160. MIDDLE EAST IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 161. MIDDLE EAST IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY AUTOIMMUNE DISORDERS, 2018-2032 (USD MILLION)
TABLE 162. MIDDLE EAST IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2032 (USD MILLION)
TABLE 163. MIDDLE EAST IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 164. AFRICA IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 165. AFRICA IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY ASSAY TYPE, 2018-2032 (USD MILLION)
TABLE 166. AFRICA IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY ANTIBODY TEST, 2018-2032 (USD MILLION)
TABLE 167. AFRICA IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 168. AFRICA IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 169. AFRICA IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 170. AFRICA IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY AUTOIMMUNE DISORDERS, 2018-2032 (USD MILLION)
TABLE 171. AFRICA IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2032 (USD MILLION)
TABLE 172. AFRICA IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 173. ASIA-PACIFIC IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 174. ASIA-PACIFIC IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY ASSAY TYPE, 2018-2032 (USD MILLION)
TABLE 175. ASIA-PACIFIC IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY ANTIBODY TEST, 2018-2032 (USD MILLION)
TABLE 176. ASIA-PACIFIC IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 177. ASIA-PACIFIC IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 178. ASIA-PACIFIC IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 179. ASIA-PACIFIC IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY AUTOIMMUNE DISORDERS, 2018-2032 (USD MILLION)
TABLE 180. ASIA-PACIFIC IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2032 (USD MILLION)
TABLE 181. ASIA-PACIFIC IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 182. GLOBAL IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 183. ASEAN IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 184. ASEAN IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY ASSAY TYPE, 2018-2032 (USD MILLION)
TABLE 185. ASEAN IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY ANTIBODY TEST, 2018-2032 (USD MILLION)
TABLE 186. ASEAN IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 187. ASEAN IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 188. ASEAN IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 189. ASEAN IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY AUTOIMMUNE DISORDERS, 2018-2032 (USD MILLION)
TABLE 190. ASEAN IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2032 (USD MILLION)
TABLE 191. ASEAN IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 192. GCC IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 193. GCC IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY ASSAY TYPE, 2018-2032 (USD MILLION)
TABLE 194. GCC IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY ANTIBODY TEST, 2018-2032 (USD MILLION)
TABLE 195. GCC IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 196. GCC IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 197. GCC IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 198. GCC IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY AUTOIMMUNE DISORDERS, 2018-2032 (USD MILLION)
TABLE 199. GCC IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2032 (USD MILLION)
TABLE 200. GCC IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 201. EUROPEAN UNION IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 202. EUROPEAN UNION IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY ASSAY TYPE, 2018-2032 (USD MILLION)
TABLE 203. EUROPEAN UNION IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY ANTIBODY TEST, 2018-2032 (USD MILLION)
TABLE 204. EUROPEAN UNION IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 205. EUROPEAN UNION IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 206. EUROPEAN UNION IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 207. EUROPEAN UNION IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY AUTOIMMUNE DISORDERS, 2018-2032 (USD MILLION)
TABLE 208. EUROPEAN UNION IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2032 (USD MILLION)
TABLE 209. EUROPEAN UNION IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 210. BRICS IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 211. BRICS IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY ASSAY TYPE, 2018-2032 (USD MILLION)
TABLE 212. BRICS IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY ANTIBODY TEST, 2018-2032 (USD MILLION)
TABLE 213. BRICS IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 214. BRICS IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 215. BRICS IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 216. BRICS IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY AUTOIMMUNE DISORDERS, 2018-2032 (USD MILLION)
TABLE 217. BRICS IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2032 (USD MILLION)
TABLE 218. BRICS IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 219. G7 IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 220. G7 IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY ASSAY TYPE, 2018-2032 (USD MILLION)
TABLE 221. G7 IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY ANTIBODY TEST, 2018-2032 (USD MILLION)
TABLE 222. G7 IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 223. G7 IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 224. G7 IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 225. G7 IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY AUTOIMMUNE DISORDERS, 2018-2032 (USD MILLION)
TABLE 226. G7 IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2032 (USD MILLION)
TABLE 227. G7 IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 228. NATO IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 229. NATO IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY ASSAY TYPE, 2018-2032 (USD MILLION)
TABLE 230. NATO IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY ANTIBODY TEST, 2018-2032 (USD MILLION)
TABLE 231. NATO IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 232. NATO IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 233. NATO IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 234. NATO IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY AUTOIMMUNE DISORDERS, 2018-2032 (USD MILLION)
TABLE 235. NATO IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2032 (USD MILLION)
TABLE 236. NATO IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 237. GLOBAL IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 238. UNITED STATES IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 239. UNITED STATES IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY ASSAY TYPE, 2018-2032 (USD MILLION)
TABLE 240. UNITED STATES IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY ANTIBODY TEST, 2018-2032 (USD MILLION)
TABLE 241. UNITED STATES IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 242. UNITED STATES IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 243. UNITED STATES IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 244. UNITED STATES IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY AUTOIMMUNE DISORDERS, 2018-2032 (USD MILLION)
TABLE 245. UNITED STATES IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2032 (USD MILLION)
TABLE 246. UNITED STATES IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 247. CHINA IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 248. CHINA IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY ASSAY TYPE, 2018-2032 (USD MILLION)
TABLE 249. CHINA IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY ANTIBODY TEST, 2018-2032 (USD MILLION)
TABLE 250. CHINA IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 251. CHINA IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 252. CHINA IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 253. CHINA IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY AUTOIMMUNE DISORDERS, 2018-2032 (USD MILLION)
TABLE 254. CHINA IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2032 (USD MILLION)
TABLE 255. CHINA IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)

Companies Mentioned

The key companies profiled in this Immunoprotein Diagnostic Testing market report include:
  • Abbott Laboratories
  • Bio-Rad Laboratories, Inc.
  • bioMérieux SA
  • Danaher Corporation
  • DiaSorin S.p.A
  • F. Hoffmann-La Roche Ltd
  • Fujirebio Inc
  • Ortho-Clinical Diagnostics, Inc.
  • Siemens Healthineers AG
  • Thermo Fisher Scientific Inc

Table Information

Report AttributeDetails
No. of Pages193
PublishedJanuary 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 10.79 Billion
Forecasted Market Value ( USD ) by 2032 $ 16.32 Billion
Compound Annual Growth Rate7.1%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Immunoprotein Diagnostic Testing Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031 - Product Image

Immunoprotein Diagnostic Testing Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031

  • Report
  • 180 Pages
  • Global
From
Immunoprotein Diagnostic Testing - Global Strategic Business Report - Product Image

Immunoprotein Diagnostic Testing - Global Strategic Business Report

  • Report
  • 171 Pages
  • Global
From
Immunoprotein Market - Global Forecast 2026-2032 - Product Image

Immunoprotein Market - Global Forecast 2026-2032

  • Report
  • 184 Pages
  • Global
From
Immunoprotein Diagnostic Testing Market Size, Share & Trends Analysis Report By Test (Immunoglobulin Diagnostic Tests), By Technology, By Application, By Distribution Channel, By End-use, By Region, And Segment Forecasts, 2025 - 2030 - Product Image

Immunoprotein Diagnostic Testing Market Size, Share & Trends Analysis Report By Test (Immunoglobulin Diagnostic Tests), By Technology, By Application, By Distribution Channel, By End-use, By Region, And Segment Forecasts, 2025 - 2030

  • Report
  • 180 Pages
  • Global
From
2025 Global Immunoprotein Testing Market: Unmet Needs, Supplier Shares and Strategies, Segment Volume and Sales Forecasts for 13 Assays, Emerging Technologies and Trends, Growth Opportunities for Suppliers - Product Image

2025 Global Immunoprotein Testing Market: Unmet Needs, Supplier Shares and Strategies, Segment Volume and Sales Forecasts for 13 Assays, Emerging Technologies and Trends, Growth Opportunities for Suppliers

  • Report
  • 297 Pages
  • Global
From

About the Immunoprotein Testing Market

Immunoprotein testing is a type of diagnostic test used to detect the presence of specific proteins in the body. These proteins are produced by the immune system in response to a variety of conditions, including infections, autoimmune diseases, and cancer. Immunoprotein tests are used to diagnose and monitor a wide range of diseases, including HIV, hepatitis, and tuberculosis. They can also be used to detect the presence of antibodies, which can indicate a previous exposure to a particular virus or bacteria. Immunoprotein tests are typically performed in a laboratory setting, using a variety of techniques such as enzyme-linked immunosorbent assays (ELISA) and immunofluorescence assays (IFA). These tests are often used in combination with other diagnostic tests, such as blood tests, to provide a more comprehensive picture of a patient's health. The immunoprotein testing market is a rapidly growing segment of the diagnostics industry. It is driven by the increasing prevalence of infectious diseases, the growing demand for personalized medicine, and the development of new technologies. Some of the major players in the immunoprotein testing market include Abbott Laboratories, Becton Dickinson, Bio-Rad Laboratories, Cepheid, DiaSorin, and Roche Diagnostics. Show Less Read more

Copyright © 2002-2026 Research and Markets. All Rights Reserved.